HomeINKT โข NASDAQ
Mink Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | โ | โ |
Operating expense | 2.53M | -33.87% |
Net income | -2.77M | 27.45% |
Net profit margin | โ | โ |
Earnings per share | -0.70 | 36.36% |
EBITDA | -2.48M | 34.27% |
Effective tax rate | โ | โ |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.23M | -44.39% |
Total assets | 4.27M | -38.10% |
Total liabilities | 26.06M | -4.17% |
Total equity | -21.79M | โ |
Shares outstanding | 3.99M | โ |
Price to book | -1.30 | โ |
Return on assets | -126.79% | โ |
Return on capital | 40.41% | โ |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.77M | 27.45% |
Cash from operations | -1.34M | 47.26% |
Cash from investing | โ | โ |
Cash from financing | 576.00 | -99.99% |
Net change in cash | -1.34M | -154.78% |
Free cash flow | -832.34K | 55.25% |
Previous close
$7.17
Day range
$6.80 - $7.55
Year range
$4.56 - $13.79
Market cap
28.82M USD
Avg Volume
11.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Website
Employees
23